Apontis Pharma AG (XTER:APPH) Gross Margin % : 61.72% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Apontis Pharma AG's Gross Profit for the six months ended in Dec. 2023 was €11.05 Mil. Apontis Pharma AG's Revenue for the six months ended in Dec. 2023 was €17.91 Mil. Therefore, Apontis Pharma AG's Gross Margin % for the quarter that ended in Dec. 2023 was 61.72%.

The historical rank and industry rank for Apontis Pharma AG's Gross Margin % or its related term are showing as below:

XTER:APPH' s Gross Margin % Range Over the Past 10 Years
Min: 62.69 Med: 63.77 Max: 72.37
Current: 62.69

During the past 6 years, the highest Gross Margin % of Apontis Pharma AG was 72.37%. The lowest was 62.69%. And the median was 63.77%.

XTER:APPH's Gross Margin % is ranked better than
76.45% of 985 companies
in the Drug Manufacturers industry
Industry Median: 47 vs XTER:APPH: 62.69

Apontis Pharma AG had a gross margin of 61.72% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Apontis Pharma AG was 0.00% per year.

Apontis Pharma AG Gross Margin % Historical Data

The historical data trend for Apontis Pharma AG's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Gross Margin % Chart

Apontis Pharma AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

72.37

63.77

66.01

62.79

62.69

Apontis Pharma AG Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Margin %	Get a 7-Day Free Trial				67.29	61.28	64.33	63.59	61.72

Competitive Comparison of Apontis Pharma AG's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Apontis Pharma AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apontis Pharma AG's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apontis Pharma AG's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Apontis Pharma AG's Gross Margin % falls into.

Apontis Pharma AG Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Apontis Pharma AG's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	23.2	/	36.964
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(36.964 - 13.793)	/	36.964
	=	62.69 %

Apontis Pharma AG's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	11.1	/	17.906
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(17.906 - 6.854)	/	17.906
	=	61.72 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Apontis Pharma AG (XTER:APPH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Apontis Pharma AG had a gross margin of 61.72% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Apontis Pharma AG Gross Margin % Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Apontis Pharma AG (XTER:APPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Alfred-Nobel-Strabe 10, Monheim, BY, DEU, 40789

Website

https://www.apontis-pharma.de

Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases.

Executives

Karlheinz Gast	Board of Directors
Thomas Milz	Board of Directors

Apontis Pharma AG (XTER:APPH) Headlines

No Headlines